Azithromycin, Cefixime, Vitamin C, Vitamin D, and Zinc to Treat Mild Covid-19: A Case Report

dc.contributor.author	Anas Khaleel
dc.contributor.author	Haidar AL Shammari
dc.contributor.author	Mohammad Niazi
dc.contributor.author	Talal Salem Al-Qaisi
dc.date.accessioned	2025-10-14T10:37:43Z
dc.date.available	2025-10-14T10:37:43Z
dc.date.issued	2021-09
dc.description.abstract	Abstract Background: COVID-19 is a novel acute respiratory disease that first emerged in 2019 and exploded into a worldwide pandemic. Symptoms range from dry cough, fatigue, fever, and pneumonia in mild cases to acute respiratory distress in critical cases. Case Report: The aim of the present case study is to illustrate the benefits of using select antibiotics and dietary supplements to treat a mild case of COVID-19. Conclusion: A combination of azithromycin, cefixime, vitamin C, vitamin D, and zinc may potentially be beneficial for the treatment of moderate COVID-19 symptoms. Keywords: COVID-19, azithromycin, cefixime, vitamin C, vitamin D, zinc
dc.identifier.citation	Khaleel, A., Shammari, H. A., Niazi, M., Al-Qaisi, T. S., Abutaleb, R., & Tarkhan, A. H. (2021). Azithromycin, Cefixime, Vitamin C, Vitamin D, and Zinc to Treat Mild Covid-19: A Case Report. Indian Journal of Forensic Medicine & Toxicology, 15(3), 2011-2014.
dc.identifier.doi	https://doi.org/10.37506/ijfmt.v15i3.15610
dc.identifier.uri	https://repository.adu.ac.ae/handle/1/7595
dc.language.iso	en
dc.publisher	ResearchGate
dc.title	Azithromycin, Cefixime, Vitamin C, Vitamin D, and Zinc to Treat Mild Covid-19: A Case Report
dc.type	Other

Files

Now showing 1 - 1 of 1